Therefore, F127ZIF‐8AB680 showed a more potent capability than AB680 in the inhibition of CD73 expression and adenosine production in EGFR‐mutant NSCLC cells, leading to enhanced DC maturation and significantly improved CD8+ T cell activation. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.